Segall Bryant & Hamill LLC Acquires New Position in Molina Healthcare, Inc $MOH

Segall Bryant & Hamill LLC acquired a new stake in Molina Healthcare, Inc (NYSE:MOH) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 161,033 shares of the company’s stock, valued at approximately $21,466,000.

Other institutional investors have also recently bought and sold shares of the company. Essential Partners LLC raised its position in shares of Molina Healthcare by 8,754.2% during the 1st quarter. Essential Partners LLC now owns 2,125 shares of the company’s stock valued at $283,000 after acquiring an additional 2,101 shares during the last quarter. Bull Harbor Capital LLC bought a new position in shares of Molina Healthcare in the 1st quarter worth $919,000. South Dakota Investment Council grew its stake in shares of Molina Healthcare by 62.9% during the first quarter. South Dakota Investment Council now owns 168,307 shares of the company’s stock worth $22,435,000 after purchasing an additional 64,985 shares during the period. Amundi grew its stake in shares of Molina Healthcare by 5.6% during the first quarter. Amundi now owns 184,765 shares of the company’s stock worth $24,629,000 after purchasing an additional 9,786 shares during the period. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Molina Healthcare by 437.6% during the first quarter. EverSource Wealth Advisors LLC now owns 3,199 shares of the company’s stock worth $426,000 after purchasing an additional 2,604 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on MOH. Mizuho set a $215.00 target price on Molina Healthcare in a research note on Monday, June 8th. Bank of America upgraded Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price for the company in a research report on Wednesday, April 29th. Barclays lowered their price target on Molina Healthcare from $184.00 to $180.00 and set an “underweight” rating for the company in a research note on Friday, July 24th. Royal Bank Of Canada cut their price target on shares of Molina Healthcare from $248.00 to $218.00 and set a “sector perform” rating on the stock in a research report on Friday, July 24th. Finally, UBS Group lifted their price objective on shares of Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a research note on Friday, May 22nd. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $202.44.

Insider Transactions at Molina Healthcare

In other news, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the sale, the insider owned 67,175 shares of the company’s stock, valued at $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares in the company, valued at $2,454,713.25. This trade represents a 4.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 1.44% of the company’s stock.

Molina Healthcare Price Performance

MOH opened at $196.10 on Friday. The stock has a market cap of $10.24 billion, a P/E ratio of -1,089.40, a P/E/G ratio of 28.02 and a beta of 0.74. Molina Healthcare, Inc has a 12 month low of $121.06 and a 12 month high of $244.89. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.95. The company has a fifty day simple moving average of $207.67 and a 200 day simple moving average of $177.58.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.12. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The firm had revenue of $10.87 billion for the quarter, compared to analyst estimates of $10.83 billion. During the same period in the previous year, the company posted $5.48 earnings per share. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. On average, research analysts expect that Molina Healthcare, Inc will post 5.29 EPS for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.